Story excerpt provided by Cincinnati Business Courier.
Written by Steve Watkins.
One of Cincinnati’s biggest venture capital firms, River Cities Capital Funds, reaped a big gain from the sale of one of its biggest holdings, but it wasn’t as much as River Cities might have hoped.
River Cities, which has raised more than $600 million for four funds to invest in growing companies, hauled in a profit from the sale of an Atlanta-based colonoscopy imaging product developer EndoChoice Holdings Inc. for $210 million to Boston Scientific (NYSE: BSX). That’s $8 a share.
Click here to read the complete article.
Originally published February 2, 2017.